title: Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumors given definitive irradiation.
abstract: OBJECTIVE
  To determine whether the expression of epidermal growth factor receptor (EGFR) protein was predictive of patient survival independently of other prognostic factors in astrocytic tumors.
  
  
  METHODS
  Epidermal growth factor receptor protein expression was investigated immunohistochemically in formalin-fixed, paraffin-embedded surgical specimens of 55 glioblastoma multiforme, 14 anaplastic astrocytoma, and 2 astrocytomas given definitive irradiation. We evaluated the relationship of EGFR protein expression and tumor grade, histologic features, age at diagnosis, sex, patient survival, and recurrence-free survival.
  
  
  RESULTS
  The percentage of tumor cells which were EGFR positive related to reduced survival by Cox regression analysis in both univariate (p = 0.0424) and multivariate analysis (p = 0.0016). Epidermal growth factor receptor positivity was the only 1 of 11 clinical and histological variables associated with decreased recurrence-free survival by either univariate (p = 0.0353) or multivariate (p=0.0182) analysis. Epidermal growth factor receptor protein expression was not related to patient age, sex, or histologic features.
  
  
  CONCLUSIONS
  Epidermal growth factor receptor positivity was a significant and independent prognostic indicator for overall survival and recurrence-free survival for irradiated patients with astrocytic gliomas.
authors.affiliation: Department of Radiation Oncology & Biophysics, Eastern Virginia Medical School, Norfolk, VA 23501, USA.
authors.forename: A
authors.initials: A
authors.lastname: Zhu
authors.forename: J
authors.initials: J
authors.lastname: Shaeffer
authors.forename: S
authors.initials: S
authors.lastname: Leslie
authors.forename: P
authors.initials: P
authors.lastname: Kolm
authors.forename: A M
authors.initials: AM
authors.lastname: El-Mahdi
mesh_terms: D001254:Astrocytoma / Q000737:chemistry* / Q000473:pathology / Q000532:radiotherapy; D014408:Biomarkers, Tumor / Q000032:analysis*; D001932:Brain Neoplasms / Q000737:chemistry* / Q000473:pathology / Q000532:radiotherapy; D002467:Cell Nucleus / Q000737:chemistry; D003593:Cytoplasm / Q000737:chemistry; D018572:Disease-Free Survival; D066246:ErbB Receptors / Q000032:analysis*; D005260:Female; D005909:Glioblastoma / Q000737:chemistry* / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013997:Time Factors
chemical_list: D014408:Biomarkers, Tumor; D066246:ErbB Receptors